Matthias Hebben
Chief Tech/Sci/R&D Officer at LOGICBIO THERAPEUTICS, INC.
Matthias Hebben active positions
| Companies | Position | Start | End |
|---|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/02/2019 | - |
Career history of Matthias Hebben
Former positions of Matthias Hebben
| Companies | Position | Start | End |
|---|---|---|---|
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Corporate Officer/Principal | 01/01/2013 | 01/02/2019 |
| VALNEVA | Corporate Officer/Principal | 01/06/2008 | 01/01/2013 |
Training of Matthias Hebben
| University of Nice Sophia Antipolis | Doctorate Degree |
| University of Strasbourg | Undergraduate Degree |
| Louis Pasteur University | Undergraduate Degree |
Statistics
International
| France | 6 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VALNEVA | Health Technology |
| Private companies | 2 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Health Technology |
- Stock Market
- Insiders
- Matthias Hebben
- Experience
